Association of Diabetes Mellitus With a Shared Hyperinflammatory Immune Response in Patients With Melioidosis and

Patpong Rongkard1,2, Barbara Kronsteiner1,2, Clare Eckold3

  • 1NDM Centre for Global Health Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.

Abstract

Insights

Diabetes mellitus (DM) exacerbates infections like melioidosis and tuberculosis by heightening inflammatory responses. This study reveals DM impairs crucial interferon signaling in tuberculosis, impacting treatment strategies.

Area of Science:

  • Infectious Diseases
  • Immunology
  • Genomics

Background:

  • Melioidosis, caused by *Burkholderia pseudomallei*, has a high fatality rate, especially in Thailand.
  • Diabetes mellitus (DM) significantly increases susceptibility to melioidosis (12-fold) and tuberculosis (3-fold).
  • The precise mechanisms linking DM to increased infection risk remain unclear.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying the impact of DM on host immune responses during melioidosis and tuberculosis.
  • To compare gene expression patterns in patients with DM and these infections against healthy controls.

Main Methods:

  • Whole-blood RNA sequencing was performed on 81 melioidosis patients (Thailand) and 151 tuberculosis patients (various countries) with matched controls.
  • Supervised and unsupervised analyses, including differential gene expression, pathway analysis, and weighted gene coexpression network analysis, were employed.

Main Results:

  • DM status correlated with hyperinflammation in both melioidosis and tuberculosis, marked by increased neutrophil/platelet degranulation and coagulation pathway activation.
  • DM led to decreased phosphoinositide 3-kinase/protein kinase B signaling in both infections.
  • Specific to melioidosis, DM increased TNF signaling and ER stress; in tuberculosis, DM distinctly reduced interferon signaling.

Conclusions:

  • DM enhances non-specific inflammatory responses in melioidosis and tuberculosis.
  • DM impairs interferon-mediated immunity in tuberculosis, suggesting potential therapeutic targets.
  • Findings have implications for developing host-directed therapies for infections in diabetic patients.

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...